Kenneth Draper

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

eScreen, Inc. develops employment screening technology and web-based applications. It offers drugs-of-abuse screening and automated hiring program solution. The company was founded by Dr. Murray Lappe in 1998 and is headquartered in Overland Park, KS.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Mercer Management Consulting, Inc. provides management consulting services. The company offers business design innovation, brand strategy, operational excellence, transformation, and portfolio strategy services. The firm was founded in 1990 and is located in New York, NY.

Emerge Diagnostics, Inc. engages in the management of musculoskeletal disorders. It offers electrodiagnostic functional assessment (EFA) test, which designed to diagnose and identify the location, extent, nature, and age of soft tissue injuries. The company was founded by Phil Reaston and MaryRose Cusimano Reaston and is headquartered in Carlsbad, CA.

Sandel Avionics, Inc. manufactures and markets display systems and other products for commercial aviation market. The company was founded by Gerald Block in 1998 and is headquartered in Vista, CA.

Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.